Atropine and Other Anticholinergic Drugs

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 287-303

  Mcdonough, John H ^a   Shih, Tsung Ming ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Atropine and anticholinergic drugs; Atropine nerve agent poisoning of humans; Iranian nerve agent casualty treatment doctrine; Nerve agent exposure with anticholinergics; Protracted CNS effects after exposure

Indexed keywords

EID: 56049121302     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch14     Document Type: Chapter

References (88)

1. Anderson DR, Gennings C, Carter WH et al. (1994). Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fund Appl Toxicol, 22, 588-593.
2. Bajgar J, Fusek J and Vachek J (1994). Treatment and prophylaxis against nerve agent poisoning. ASA Newslett, 99(4), 10-11.
3. Bowers MB, Goodman E and Sim VN (1964). Some behavioral changes in man following anticholinesterase administration. J Nerv Ment Dis, 138, 383-389.
4. Brimblecombe RW, Green DM, Stratton JA et al. (1970). The protective actions of some anticholinergic drugs in sarin poisoning. Br J Pharmacol, 39, 822-830.
5. Brown JH and Taylor P (2001). Muscarinic receptor agonists and antagonists. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition (JG Hardman, LE Limbird and AG Gilman, Eds), pp. 155-173. New York, NY, USA: McGrow-Hill.
6. Bymaster FP, Carter PA, Yamada M et al. (2003). Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis and pilocarpineinduced seizure activity. Eur J Neurosci, 17, 1403-1410.
7. Capacio BR and Shih T-M (1991). Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia, 32, 604-615.
8. Carpentier P, Foquin-Tarricone A, Bodjarian N et al. (1994). Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology, 15, 837-852.
9. Caulfield MP and Birdsall NJ (1998). International Union of Pharmacology XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev, 50, 279-290.
10. Coleman IW, Little PE and Bannard RAB (1962). Cholinolytics in the treatment of anticholinesterase poisoning. I. The effectiveness of certain cholinolytics in combination with an oxime for treatment of sarin poisoning. Can J Biochem Pharmacol, 40, 815-826.
11. Coleman IW, Patton GE and Bannard RAB (1968). Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol, 46, 109-117.
12. Comstock CC and Krop S (1948). German first aid kits for treatment of tabun (GA) casualties. Medical Division Report No. 151. Edgewood Arsenal, MD, USA: Army Chemical Center.
13. Dawson RM (1994). Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol, 14, 317-331.
14. Departments of the Army, Navy, Air Force and Commandant Marine Corps (1995). Field Manual: Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries. Army FM-8-285; Navy NAVMED P-5041; Air Force AFJMAN 44-149; Marine Corps FMFM 11-11. Washington, DC, USA (December).
15. Eddleston M, Buckley NA, Checketts H et al. (2004a). Speed of initial atropinisation in significant organophosphorus pesticide poisoning-a systematic comparison of recommended regimens. J Toxicol Clin Toxicol, 42, 852-862.
16. Eddleston M, Dawson A, Karalliedde L et al. (2004b). Early management after self-poisoning with an organophosphorus or carbamate pesticide-a treatment protocol for junior doctors. Crit Care, 8, R391-R397.
17. Fosbraey P, Wetherell JR and French MC (1990). Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J Neurochem, 54, 72-79.
18. Gomeza J, Shannon HE, Kostenis E et al. (1999). Pronounced pharmacological deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Nat Acad Sci USA, 96, 1692-1697.
19. Green DM, Muir AW, Stratton JA et al. (1977). Dual mechanisms of antidotal action of atropinelike drugs in poisoning by organophosphorus anticholinesterases. J Pharm Pharmacol, 29, 62-64.
20. Grob D (1956). The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. AMA Arch Intern Med, 98, 221-239.
21. Grob D and Harvey AM (1953). The effects and treatment of nerve gas poisoning. Am J Med, 14, 52-63.
22. Grob D and Harvey AM (1958). The effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphnonofluoridate). J Clin Invest, 37, 350-368.
23. Grob D, Harvey AM, Langworthy OR et al. (1947). The administration of di-isopropyl fluororphosphate (DFP) to man, III: Effect on the central nervous system with special reference to the electrical activity of the brain. Bull Johns Hopkins Hosp, 81, 257-266.
24. Hamilton SE, Loose MD, Qi M et al. (1997). Disruption of the M1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Nat Acad Sci USA, 94, 13311-13316.
25. Headley DB (1982). Effects of atropine sulfate and pralidoxime chloride on visual, physiological, performance, subjective and cognitive variables in man: A review. Milit Med, 147, 122-132.
26. Jovic R and Milosevic M (1970). Effective doses of some cholinolytics in the treatment of anticholinesterase poisoning. Eur J Pharmacol, 12, 85-93.
27. Kassa J (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol, 40, 803-816.
28. Kassa J and Bajgar J (1996). The influence of pharmacological pretreatment on efficacy of HI-6 oxime in combination with benactyzine in soman poisoning in rats. Human Exp Toxicol, 15, 383-388.
29. Ketchum JS, Sidell FR, Crowell EB et al. (1973). Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man. Psychopharmacologia, 28, 121-145.
30. Koelle GB (1963). Cholinesterases and anticholinesterase agents. In: Handbuch der Experimentellen Pharmakologie, Volume 15 (O Eichler and A Farah, eds) 989-1027. Berlin, Germany: Springer-Verlag.
31. Kunkel AM, O'Leary JF and Jones AH (1973). Atropine-induced ventricular fibrillation during cyanosis caused by organophosphorus poisoning. Edgewood Arsenal Technical Report 4711. Edgewood Arsenal, MD, USA: Medical Research Laboratory.
32. Lallement G, Denoyer M, Collet A et al. (1992). Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci Lett, 139, 104-107.
33. Lallement G, Pernot-Marino I, Foquin-Tarricone A et al. (1994). Modulation of soman-induced neuropathology with an anticonvulsant regimen. NeuroReport, 5, 2265-2268.
34. Lallement G, Clarencon D, Masqueliez C et al. (1998). Nerve agent poisoning in primates: antilethal, antiepileptic and neuroprotective effects of GK-11. Arch Toxicol, 72, 84-92.
35. Leadbeater L, Inns RH and Rylands JM (1985). Treatment of poisoning by soman. Fund Appl Toxicol, 5, S225-S231.
36. LeBlanc FN, Benson BE and Gilg AD (1986). Asevere organophosphate poisoning requiring the use of an atropine drip. Clin Toxicol, 24, 69-76.
37. Lemercier G, Carpentier P, Sentenac-Roumanou H et al. (1983). Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol (Berlin), 61, 123-129.
38. Lipp JA (1972). Effect of diazepam upon somaninduced seizure activity and convulsions. EEG Clin Neurophysiol, 32, 557-560.
39. Lipp JA (1973). Effects of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch Int Pharmacodynam Ther, 202, 244-251.
40. Lipp JA (1976). Effect of atropine upon the cardiovascular system during soman-induced respiratory depression. Arch Int Pharmacodynam Ther, 220, 19-27.
41. Lipp JA and Dola TJ (1978). Effect of atropine upon the cerebrovascular system during soman-induced respiratory depression. Arch Int Pharmacodynam Ther, 235, 211-218.
42. Longo VG (1966). Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol Rev, 18, 965-996.
43. Masuda N, Takatsu M, Morinari H et al. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446.
44. McDonough JH (2002). Performance impacts of nerve agents and their pharmacological countermeasures. Milit Psychol, 14, 93-119.
45. McDonough JH and Shih T-M (1993). Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev, 17, 203-215.
46. McDonough JH and Shih T-M (1995). A study of the N-methyl-d-aspartate antagonist properties of anticholinergic drugs. Pharmacol Biochem Behav, 51, 249-253.
47. McDonough JH, Jaax NK, Crowley RA et al. (1989). Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fund Appl Toxicol, 13, 256-276.
48. McDonough JH, Dochterman LW, Smith CD et al. (1995). Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology, 15, 123-132.
49. McDonough JH and Shih T-M (1997). Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev, 21, 559-579.
50. McDonough JH, Zoeffel LD, McMonagle J et al. (2000). Anticonvulsant treatment for nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilep Res, 38, 1-14.
51. Medical Management of Chemical Casualties Handbook (2000). 3rd Edition, pp. 102-135. Aberdeen Proving Ground, MD, USA: Chemical Casualty Care Division, USAMRICD.
52. Meshulam Y, Cohen G, Chapman S et al. (2001). Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine. J Appl Toxicol, 21(Supplement 1), S75-S78.
53. Moore DH, Clifford CB, Crawford IT et al. (1995). Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In Enzymes of Cholinesterase Family (DM Quinn, AS Balasubramanian, BP Doctor and P Taylor, eds), pp. 297-304. New York, NY, USA: Plenum Press.
54. Morita H, Yanaagisawa N, Nakajima T et al. (1995). Sarin poisoning in Matsumoto, Japan. Lancet, 346, 290-293.
55. Nakajima T, Ohta S, Morita H et al. (1997). Epidemiological study of sarin poisoning in Matsumoto City, Japan. J Epidemiol, 8, 33-41.
56. Newmark J (2004). The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology, 62, 1590-1596.
57. Nozaki H and Aikawa N (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446-1447.
58. Nozaki H, Aikawa N, Fujishima S et al. (1995). A case ofVXpoisoning and the difference from sarin. Lancet, 346, 698-699.
59. Ohbu S, Yamashina A, Takasu N et al. (1997). Sarin poisoning on Tokyo subway. Southern Med J, 90, 587-593.
60. Okumura T, Takasu N, Ishimatsu S et al. (1996). Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med, 28, 129-135.
61. Olney JA, Price MT, Labruyere J et al. (1987). Anti-Parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol, 142, 319-320.
62. Pazdernik TL, Cross R, Nelson SR et al. (1983). Soman-induced depression of brain activity in TAB-pretreated rats: a 2-deoxyglucose study. Neurotoxicology, 4, 27-34.
63. Penetar DM (1990). A brief review of atropine effects on physiology and performance. Drug Develop Res, 20, 117-121.
64. Petrov AN, Sofronov GA, Nechiporenko SP et al. (2004). Organophosphorus poison antidotes (in Russian). Ross Khim Zhur (Russ J Chem), 48, 110-116.
65. Philippens IH, Melchers BP, Oliver B et al. (2000). Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav, 65, 175-182.
66. Pickworth WB, Herning RI, Koeppl B et al. (1990). Dose-dependent atropine-induced changes in spontaneous electroencephalogram in human volunteers. Milit Med, 155, 166-170.
67. Rotenberg JS and Newmark J (2003). Nerve agent attacks on children: diagnosis and management. Pediatrics, 112, 648-658.
68. Rump S, Grudzinska E and Edelwein Z (1972). Effects of diazepam on abnormalities of bioelectrical activity of the rabbit's brain due to fluostigmine. Acta Nerv Super (Prague), 14, 176-177.
69. Rump S, Grudzinska E and Edelwein Z (1973). Effects of diazepam on epileptiform patterns of bioelectric activity of the rabbit's brain induced by fluostigmine. Neuropharmacology, 12, 813-817.
70. Samson FE, Pazdernik TL, Cross RS et al. (1985). Brain regional activity and damage associated with organophosphate induced seizures: effects of atropine and benactyzine. ProcWest Pharmacol Soc, 28, 183-185.
71. Sekijima Y, Morita H, Shindo M et al. (1995). A case of severe sarin poisoning in the sarin attack at Matsumoto-one-year follow-up on the clinical findings and laboratory data (in Japanese). Rin Shinkeij (Clin Neurol), 35, 1241-1245.
72. Shih T-M (1982). Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacologia (Berlin), 78, 170-175.
73. Shih T-M and McDonough JH (2000). Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. Arch Toxicol, 74, 165-172.
74. Shih T-M, Duniho SM and McDonough JH (2003). Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol, 188, 69-80.
75. Sidell FR (1974). Soman and sarin: Clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol, 7, 1-17.
76. Sidell FR (1997). Nerve agents. In: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare (R Zajtchuk, ed.), pp. 129-179. Washington, DC, USA: Office of the Surgeon General.
77. Sidell FR, Markis JE, Groff WA et al. (1974). Enhancement of drug absorption after administration by an automatic injector. J Pharmacokin Biopharm, 2, 197-210.
78. Sparenborg S, Brennecke LH, Jaax NK et al. (1992). Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology, 31, 357-368.
79. Taylor P (2001). Anticholinesterase agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition (JG Hardman, LE Limbard and AG Gilman, eds), pp. 175-191. New York, NY, USA: McGraw-Hill.
80. Vale JA, Meredith TJ and Heath A (1990). High dose atropine in organophosphorus poisoning. Postgrad Med J, 66, 881.
81. Vojvodic VB and Maksimovic M (1972). Absorption and excretion of pralidoxime in man after intramuscular injection of PAM-2Cl and various cholinolytics. Eur J Clin Pharmacol, 5, 58-61.
82. Vojvodic VB, Jovic R, Rosic N et al. (1972). Effect of a mixture of atropine, benactyzine, and pralidoxime on the body and on certain of the elements of the fighting qualities of people-volunteers. Vojnosan Pregl, 29, 103-107.
83. Wetherell JR (1994). Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol, 46, 1023-1028.
84. Wetherell J, Hall T and Passingham S (2002). Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea pig. Neurotoxicology, 23, 341-349.
85. Wills JH (1963). Pharmacological antagonists of the anticholinesterase agents. In Handbuch der Experimentellen Pharmakologie, Volume 15 (O Eichler and A Farah, eds), pp. 883-920. Berlin, Germany: Springer-Verlag.
86. Wills JH, McNamara BP and Fine EA (1950). Ventricular fibrillation in delayed treatment of TEPP poisoning. Fed Proc, 9, 136.
87. Wilson KW (late 1970s). Personal Communication. Aberdeen Proving Ground, MD, USA: Biomedical Laboratory, Chemical Systems Laboratories.
88. Yamada M, Lamping KG, Duttaroy A et al. (2001). Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc Nat Acad Sci USA, 98, 14096-14101.